![European Monitoring Centre for Drugs and Drug Addiction [new window]](/design/plain/images/left_top_menu/emcdda.gif)
![Rada vlády pro koordinaci protidrogové politiky [new window]](/design/plain/images/left_top_menu/rvkpp.gif)
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License.
drogy-info.cz / English / monitoring and research / HCV seroprevalence (seroincidence) study
HCV seroprevalence (seroincidence) study
HCV prevalence and incidence study is coordinated by Czech Netional Focal Point. It has been carrying out since September 2002. Seroprevalence study was ended in December 2003. Since February 2003 seroincidence (follow-up) study on negative found clients has been started .
See:
-
Seroprevalence study manual (140,50 kB)
-
Seroincidence study manual (122,00 kB)
-
Questionnaire, Module I (63,50 kB)
-
Questionnaire, Module II (30,50 kB)
-
Questionnaire, Module III (24,00 kB) (for determination of ITRs for prevalence estimate multiplier treatment method )
-
Questionnaire, Module IV (29,50 kB)
-
Seroincidence Module Questionnaire (70,00 kB)
Připojené soubory
| knowledge module .doc (30,50 kB) |
| modul multiplicator.doc (24,00 kB) |
| module syringe exchange.doc (29,50 kB) |
| seroprevalencestudybasic module.doc (63,50 kB) |
| vhc_study_prevalence_manual.doc (140,50 kB) |
| vhc_study_prospective_manual.doc (122,00 kB) |
| vhc_study_prospective_quest.doc (70,00 kB) |
Publikováno: 24.06.2004
Aktualizováno: 05.10.2005